Prescription Drug Pricing Reduction Act of 2019
Latest action · Sep 25, 2019 Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedSep 25, 2019
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Prescription Drug Pricing Reduction Act of 2019
This bill alters several programs and requirements relating to the prices of prescription drugs under Medicare and Medicaid.
Among other things, the bill
- requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for certain drugs covered under Medicare for which the average manufacturer price increases faster than inflation;
- requires drug manufacturers to issue rebates to the CMS for discarded amounts of certain single-dose drugs covered under Medicare, based on information reported by providers;
- reduces the annual out-of-pocket spending threshold, and eliminates beneficiary cost-sharing above this threshold, under the Medicare prescription drug benefit;
- requires the CMS to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to drug discounts and rebates, and payments between PBMs, health plans, and pharmacies;
- requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and
- increases the maximum rebate payable by drug manufacturers under the Medicaid Drug Rebate Program.
Cosponsors
Members who signed on, in the order they did.
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Reported as an original measure Sep 25, 2019 |
Actions 3
Everything that happened, newest first.
- Sep 25, 2019Introduced in Senate
- Sep 25, 2019Committee on Finance. Original measure reported to Senate by Senator Grassley. With written report No. 116-120.
- Sep 25, 2019Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
In the Congressional Record 20
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S5899 | Chuck Grassley R-IA | Sep 30, 2020 |
| Senate | Debate and remarks S2901 | Chuck Grassley R-IA | Jun 11, 2020 |
| Senate | Debate and remarks S2839 | Chuck Grassley R-IA | Jun 10, 2020 |
| Senate | Debate and remarks S2747 | Chuck Grassley R-IA | Jun 8, 2020 |
| Senate | Debate and remarks S2635 | Chuck Grassley R-IA | Jun 2, 2020 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Sep 26, 2019Status of CBO’s cost estimate for S. 2543, the Prescription Drug Pricing Reduction Act of 2019Letter to the Honorable Chuck Grassley
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46741 | Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress | Report | Mar 31, 2021 |
Related bills 11
Companion bills and other measures the record links to this one.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- An original bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.
- Short Title(s) as Reported to Senate
- Prescription Drug Pricing Reduction Act of 2019
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Accounting and auditing
- Administrative law and regulatory procedures
- Appropriations
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Fraud offenses and financial crimes
- Genetics
- Government information and archives
- Government studies and investigations
- Health
- Health care costs and insurance
- Health care coverage and access
- Health care quality
- Health technology, devices, supplies
- Home and outpatient care
- Hospital care
- Indian social and development programs
- Inflation and prices
- Intergovernmental relations
- Manufacturing
- Medicaid
- Medical ethics
- Medicare
- Minority health
- Prescription drugs
- Public contracts and procurement
- Public participation and lobbying
- Retail and wholesale trades
- Social work, volunteer service, charitable organizations
- State and local government operations
Text 1
Each version as it was printed, newest first.
- Sep 25, 2019Reported to Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
